Impact of SGLT2 inhibitors on patient outcomes: a network meta-analysis

BACKGROUND: A comprehensive network meta-analysis comparing the effects of individual sodium-glucose cotransporter 2 (SGLT2) inhibitors on patients with and without comorbidities including diabetes mellitus (DM), heart failure (HF), and chronic kidney disease (CKD) has not been previously conducted....

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jui-Yi, Pan, Heng-Chih, Shiao, Chih-Chung, Chuang, Min-Hsiang, See, Chun Yin, Yeh, Tzu-Hsuan, Yang, Yafei, Chu, Wen-Kai, Wu, Vin-Cent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612254/
https://www.ncbi.nlm.nih.gov/pubmed/37891550
http://dx.doi.org/10.1186/s12933-023-02035-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612254/
https://www.ncbi.nlm.nih.gov/pubmed/37891550
http://dx.doi.org/10.1186/s12933-023-02035-8

Ejemplares similares